Publications by authors named "James Slack"

Claim this Profile
A
Allogeneic stem cell transplantation in chronic myelomonocytic leukemia: analysis of post-transplant survival and risk factors in 138 Mayo Clinic patients.
Ali Alsugair, Estefania Gauto Mariotti, Mohammad M Alhousani, Saubia Fathima, Muhammad Yousuf, James Slack

Blood Cancer J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does early chimerism testing predict outcomes after allogeneic hematopoietic stem cell transplantation?
Luke Mountjoy, Jeanne Palmer, Katie L Kunze, Nandita Khera, Lisa Z Sproat, James L Slack

Leuk Lymphoma· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes with low dose anti-thymocyte globulin in patients undergoing matched unrelated donor allogeneic hematopoietic cell transplantation.
Luke Mountjoy, Tania Jain, Katie L Kunze, Nandita Khera, Lisa Z Sproat, James L Slack

Leuk Lymphoma· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretransplant body mass index on outcomes of allogeneic hematopoietic stem cell transplantation.
Justin Tai, Matthew Buras, Jose Leis, Pierre Noel, Jeanne Palmer, James Slack

Bone Marrow Transplant· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early post-transplantation factors predict survival outcomes in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis.
Tania Jain, Katie L Kunze, Luke Mountjoy, Daniel K Partain, Heidi Kosiorek, James L Slack

Blood Cancer J· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal analyses of refractory testicular germ cell tumors.
Michael T Barrett, Elzbieta Lenkiewicz, Smriti Malasi, Melissa Stanton, James Slack

PLoS One· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early fluctuations in busulfan levels with therapeutic dose monitoring during allogeneic stem cell transplantation: do they matter?
Tania Jain, Katie L Kunze, Banveet K Khetarpal, Margaret R McCallen, Jeffrey A Betcher, James L Slack

Leuk Lymphoma· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosis.
Tania Jain, Katie L Kunze, M'hamed Temkit, Daniel K Partain, Mrinal S Patnaik, James L Slack

Bone Marrow Transplant· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single dose versus multiple doses of rituximab for preemptive therapy of Epstein-Barr virus reactivation after hematopoietic cell transplantation.
Tania Jain, Heidi E Kosiorek, Thomas E Grys, Shu Ting Kung, Vishal S Shah, James L Slack

Leuk Lymphoma· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decitabine Induced Delayed Cardiomyopathy in Hematologic Malignancy.
Pradyumna Agasthi, Hemalatha Narayanasamy, Dan Sorajja, James Slack, Farouk Mookadam

Case Rep Cardiol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML.
Courtney D DiNardo, Eytan M Stein, Stéphane de Botton, Gail J Roboz, Jessica K Altman, James L Slack

N Engl J Med· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic hematopoietic stem cell transplant overcomes the adverse survival effect of very high risk and unfavorable karyotype in myelofibrosis.
Ayalew Tefferi, Daniel K Partain, Jeanne M Palmer, James L Slack, Vivek Roy

Am J Hematol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelial cell damage in idiopathic pneumonia syndrome.
Thomas Altmann, James Slack, Mary A Slatter, Christopher O'Brien, Andrew Cant

Bone Marrow Transplant· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of hematopoietic cell transplantation for DNA double-strand break repair disorders.
James Slack, Michael H Albert, Dmitry Balashov, Bernd H Belohradsky, Alice Bertaina

J Allergy Clin Immunol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microbiologic yield of bronchoalveolar lavage specimens from stem cell transplant recipients.
Kenneth K Sakata, Christine L Klassen, Kathryn B Bollin, Thomas E Grys, James L Slack

Transpl Infect Dis· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytogenetic Evolution in Myeloid Neoplasms at Relapse after Allogeneic Hematopoietic Cell Transplantation: Association with Previous Chemotherapy and Effect on Survival.
Natalie Ertz-Archambault, Heidi Kosiorek, James L Slack, Melissa L Lonzo, Patricia T Greipp

Biol Blood Marrow Transplant· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502.
Steven M Devine, Kouros Owzar, William Blum, Flora Mulkey, Richard M Stone, James Slack

J Clin Oncol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of race and ethnicity on outcomes and health care utilization after allogeneic hematopoietic cell transplantation.
Nandita Khera, Yu-Hui Chang, James Slack, Veena Fauble, Jose F Leis

Leuk Lymphoma· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamics of leukemia stem-like cell extinction in acute promyelocytic leukemia.
Benjamin Werner, Robert E Gallagher, Elisabeth M Paietta, Mark R Litzow, Martin S Tallman, James L Slack

Cancer Res· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Financial burden in recipients of allogeneic hematopoietic cell transplantation.
Nandita Khera, Yu-hui Chang, Shahrukh Hashmi, James Slack, Timothy Beebe

Biol Blood Marrow Transplant· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and outcome of pancreatitis in children and young adults with acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003.
Sujith Samarasinghe, Sunita Dhir, James Slack, Prasad Iyer, Rachel Wade

Br J Haematol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced toxicity conditioning and allogeneic stem cell transplantation in adults using fludarabine, carmustine, melphalan, and antithymocyte globulin: outcomes depend on disease risk index but not age, comorbidity score, donor type, or human leukocyte antigen mismatch.
James L Slack, Amylou C Dueck, Veena D Fauble, Lisa O Sproat, Craig B Reeder

Biol Blood Marrow Transplant· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic stem cell transplantation for myeloproliferative neoplasm in blast phase.
Chad Cherington, James L Slack, Jose Leis, Roberta H Adams, Craig B Reeder

Leuk Res· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNAi screening of the kinome with cytarabine in leukemias.
Raoul Tibes, James M Bogenberger, Leena Chaudhuri, R Tanner Hagelstrom, Donald Chow, James Slack

Blood· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group.
Martin S Tallman, Haesook T Kim, Pau Montesinos, Frederick R Appelbaum, Javier de la Serna, James L Slack

Blood· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis